Vividion announces publication on discovery and preclinical study of small molecules activating KEAP1 via a covalent molecular glue to degrade NRF2.
Proceedings of the National Academy of Sciences of the United States of America, Vol. 119, No. 16 (April 19, 2022), pp. 1-10 (10 pages) Allosteric modulators of G-protein-coupled receptors (GPCRs) ...
Vanqua Bio Inc. announced that its development candidate VQ-101, a best-in-class brain-penetrant small-molecule allosteric activator of glucocerebrosidase (GCase), will enter clinical development in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback